Welcome to LookChem.com Sign In|Join Free

CAS

  • or

55154-71-7

Post Buying Request

55154-71-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

55154-71-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 55154-71-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,1,5 and 4 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 55154-71:
(7*5)+(6*5)+(5*1)+(4*5)+(3*4)+(2*7)+(1*1)=117
117 % 10 = 7
So 55154-71-7 is a valid CAS Registry Number.

55154-71-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name N-[2-[2-(diethylamino)ethylamino]-5-nitrophenyl]-2-(4-ethoxyphenyl)acetamide

1.2 Other means of identification

Product number -
Other names N-(2-(2-(diethylamino)ethylamino)-5-nitrophenyl)acetamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:55154-71-7 SDS

55154-71-7Relevant articles and documents

-

Carroll,Coleman

, p. 318,319 (1975)

-

NOpiates: Novel dual action neuronal nitric oxide synthase inhibitors with μ-opioid agonist activity

Renton, Paul,Green, Brenda,Maddaford, Shawn,Rakhit, Suman,Andrews, John S.

, p. 227 - 231 (2012/05/04)

A novel series of benzimidazole designed multiple ligands (DMLs) with activity at the neuronal nitric oxide synthase (nNOS) enzyme and the μ-opioid receptor was developed. Targeting of the structurally dissimilar heme-containing enzyme and the μ-opioid GPCR was predicated on the modulatory role of nitric oxide on μ-opioid receptor function. Structure-activity relationship studies yielded lead compound 24 with excellent nNOS inhibitory activity (IC50 = 0.44 μM), selectivity over both endothelial nitric oxide synthase (10-fold) and inducible nitric oxide synthase (125-fold), and potent μ-opioid binding affinity, Ki = 5.4 nM. The functional activity as measured in the cyclic adenosine monosphospate secondary messenger assay resulted in full agonist activity (EC50 = 0.34 μM). This work represents a novel approach in the development of new analgesics for the treatment of pain.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 55154-71-7